ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 250

Fibromyalgia Patients Do Not Appear to Obsess about Their Symptoms Compared with Other Rheumatic Disease Patients

Robert S. Katz1 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibromyalgia and rheumatic disease

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

We wanted to know if fibromyalgia patients tend to obsess about their symptoms, and whether this might aggravate the complaints that they experience. We administered an obsessive-compulsive disease scale (1-3 for each question), as part of a questionnaire to patients in an office rheumatology practice.

Methods:

Patients in an office rheumatology practice were given a questionnaire, which included a scale of obsessive-compulsive symptoms. The obsessive-compulsive questions were the following (each question 1-3):

  1. I am worried about dirt, germs, and viruses.
  2. I wash my hands very often or in a special way to be sure that I am not dirty or contaminated.
  3. I must check the stove or other electrical appliances that I have locked the door, to make sure that things have not disappeared.
  4. I get a compelling urge to put my things in a special order.
  5. Do you have unwanted ideas, images, or impulses that seem silly, nasty or horrible?
  6. Do you persistently engage in actions or behaviors that you feel compelled to do, but seem to make little sense and are unrewarding?

Results:

There were 160 females and 31 males in the fibromyalgia syndrome group, and 82 females and 48 males in the non-fibromyalgia rheumatic disease patient group. The mean age of the fibromyalgia patients was 52.45 years for females and 50.39 years for males. The mean age of the patients with other rheumatic disease was 55.23 years for females and 54.02 years for males. 66.5% of the FMS patients and 57.7% of the no-FMS patients were married. The mean HAQ scores in FMS patients was 3.1 and in non-FMS rheumatic disease patients was 1.7 (p 0.001). Fibromyalgia syndrome (FMS) patients met the 2010 ACR criteria for the diagnosis.

The obsessive-compulsive scale symptom total was 15.7 in FMS patients and 15.7 in non FMS rheumatic disease patients. p 0.84. The results were not statistically significant.

Conclusion:

Patients with fibromyalgia do not appear to be more obsessive-compulsive compared to rheumatic disease controls. Though fibromyalgia patients often have intense subjective symptoms, they do not appear to become more obsessive about their health problems, compared to non FMS rheumatic disease patients.


Disclosure: R. S. Katz, None; J. L. Polyak, None.

To cite this abstract in AMA style:

Katz RS, Polyak JL. Fibromyalgia Patients Do Not Appear to Obsess about Their Symptoms Compared with Other Rheumatic Disease Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fibromyalgia-patients-do-not-appear-to-obsess-about-their-symptoms-compared-with-other-rheumatic-disease-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibromyalgia-patients-do-not-appear-to-obsess-about-their-symptoms-compared-with-other-rheumatic-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology